Graphdiyne Oxide Effective Against AML Caused by DNMT3A Mutation

Date 30th, Sep 2022
Source AZoNano - Nanotechnology Websites

DESCRIPTION

Targeted therapies selectively block essential biochemical pathways or mutant proteins required for tumor cell growth and survival.